Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Nanotech Indonesia Global Tbk (NANO) Fair Value & Analysis

Healthcare · ID · Market cap 90.0B IDR

Price23.00 IDR
Fair Value10.55 IDR
Upside-54.1%
Quality92/100
Evidence: High Range 7.91 IDR – 13.18 IDR

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Nanotech Indonesia Global Tbk (NANO) currently trades at 23.00 IDR, while our model-based Fair Value estimate is 10.55 IDR — implying the stock looks roughly 54.1% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

PT Nanotech Indonesia Global Tbk provides technology and engineering research and development services in Indonesia. The company operates in two segments, Service and Trading. It engages in travel agencies, bureau, tourism, nature tourism information, management consulting, employment, and education businesses, as well as operates in the manufacturing and trading industries. The company was incorporated in 2019 and is headquartered in South Tangerang, Indonesia. PT Nanotech Indonesia Global Tbk is a subsidiary of PT Nanotech Investama Sedaya.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is PT Nanotech Indonesia Global Tbk (NANO) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 10.55 IDR versus a price of 23.00 IDR — about −54% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NANO?
Our 21-model fair value for PT Nanotech Indonesia Global Tbk is 10.55 IDR (as of Jun 24, 2026), built from audited fundamentals. The current price is 23.00 IDR.
What is the quality score of NANO?
PT Nanotech Indonesia Global Tbk has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.